Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, announced that it has launched its blood-based colorectal cancer screening test, ShieldTM, in collaboration with Samsung Medical Center in South Korea.
Zydus and Guardant Health to jointly promote the Guardant360® portfolio of nextgeneration genomic tests for advanced solid cancers in India and Nepal equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.
Zydus Lifesciences Partners With Guardant Health To Promote Precision Oncology Tests In India and Nepal freepressjournal.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from freepressjournal.in Daily Mail and Mail on Sunday newspapers.
Guardant360 is a minimally invasive liquid biopsy test that provides comprehensive genomic profiling of all solid tumours by analysing circulating tumour DNA (ctDNA) from a simple blood draw.
Zydus Lifesciences to co-promote Guardant Health biopsy tests in India and Nepal thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.